• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Is there difference between anastomotic site and remnant stump carcinoma in gastric stump cancers?-a single institute analysis of 90 patients.胃残端癌的吻合口部位癌与残端癌之间有差异吗?——对90例患者的单机构分析
J Gastrointest Oncol. 2019 Apr;10(2):307-313. doi: 10.21037/jgo.2018.12.03.
2
[Study on the clinicopathologic characteristics and prognostic difference of gastric stump cancer between non-anastomotic site and anastomotic site].[非吻合口部位与吻合口部位胃残端癌的临床病理特征及预后差异研究]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jan 25;20(1):67-72.
3
[Meta-analysis of gastric stump cancer after gastrectomy for gastric cancer].[胃癌胃切除术后残胃癌的荟萃分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):569-577.
4
[Retrospective clinical analysis of surgical treatment for gastric stump carcinoma].残胃癌手术治疗的回顾性临床分析
Zhonghua Wai Ke Za Zhi. 2016 Mar 1;54(3):182-6. doi: 10.3760/cma.j.issn.0529-5815.2016.03.006.
5
[Comparison of clinicopathological features and prognosis analysis between gastric stump cancer and recurrence of gastric cancer after radical gastrectomy].胃残端癌与胃癌根治术后复发的临床病理特征比较及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):507-513.
6
Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach.良性胃十二指肠病变远端部分胃切除术后胃残端癌与胃上三分之一原发性癌的临床病理差异
Cancer. 1994 Jan 1;73(1):15-21. doi: 10.1002/1097-0142(19940101)73:1<15::aid-cncr2820730105>3.0.co;2-j.
7
Current state of gastric stump carcinoma in Japan: based on the results of a nationwide survey.日本胃残胃癌的现状:基于全国性调查的结果。
World J Surg. 2010 Jul;34(7):1540-7. doi: 10.1007/s00268-010-0505-5.
8
Signet-ring cell carcinoma arising in the gastric stump after duodenopancreatectomy for ductal adenocarcinoma of the pancreas: a case report.胰管腺癌行十二指肠胰切除术后胃残端发生的印戒细胞癌:一例报告
Clin Med Oncol. 2008;2:109-12. doi: 10.4137/cmo.s384. Epub 2008 Mar 27.
9
Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?胃大部切除术治疗良性病变胃远端切除术后吻合口残胃癌是否可行?
World J Surg Oncol. 2020 Feb 27;18(1):43. doi: 10.1186/s12957-020-01821-y.
10
Prognosis and clinicopathologic features in patients with gastric stump cancer after curative surgery.胃大部切除术后残胃癌患者的预后及临床病理特征。
Curr Oncol. 2020 Jun;27(3):e259-e264. doi: 10.3747/co.27.6017. Epub 2020 Jun 1.

引用本文的文献

1
Predictive value of positive lymph node ratio in patients with locally advanced gastric remnant cancer.局部进展期残胃癌患者阳性淋巴结比率的预测价值
World J Gastrointest Oncol. 2024 Mar 15;16(3):833-843. doi: 10.4251/wjgo.v16.i3.833.
2
Does gastric stump cancer really differ from primary proximal gastric cancer? A multicentre, propensity score matching-used, retrospective cohort study.胃残端癌真的与原发性近端胃癌不同吗?一项多中心、使用倾向评分匹配的回顾性队列研究。
World J Gastrointest Surg. 2023 Nov 27;15(11):2553-2563. doi: 10.4240/wjgs.v15.i11.2553.
3
Appraisal of gastric stump carcinoma and current state of affairs.胃残端癌评估及现状
World J Clin Cases. 2023 May 6;11(13):2864-2873. doi: 10.12998/wjcc.v11.i13.2864.
4
Remnant gastric cancer: An ordinary primary adenocarcinoma or a tumor with its own pattern?残胃癌:是普通的原发性腺癌还是具有自身特征的肿瘤?
World J Gastrointest Surg. 2021 Apr 27;13(4):366-378. doi: 10.4240/wjgs.v13.i4.366.
5
Meta-Analysis Reveals the Prognostic Relevance of Nuclear and Membrane-Associated Bile Acid Receptors in Gastric Cancer.Meta 分析揭示核和膜相关胆汁酸受体在胃癌中的预后相关性。
Clin Transl Gastroenterol. 2021 Jan 12;12(1):e00295. doi: 10.14309/ctg.0000000000000295.

本文引用的文献

1
[Progress and controversy on diagnosis and treatment of gastric stump cancer].[残胃癌诊断与治疗的进展及争议]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):588-592.
2
[Meta-analysis of gastric stump cancer after gastrectomy for gastric cancer].[胃癌胃切除术后残胃癌的荟萃分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):569-577.
3
[Clinicopathological characteristics and prognostic factor analysis of carcinoma in remnant stomach cancer at Peking University Cancer Hospital].[北京大学肿瘤医院残胃癌的临床病理特征及预后因素分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):522-528.
4
[Epidemiological characteristics and inducing factors of gastric stump cancer].[残胃癌的流行病学特征及诱发因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):498-501.
5
[Interpretation on Chinese surgeons' consensus opinion for the definition of gastric stump cancer (version 2018)].《中国外科医生关于胃残端癌定义的专家共识解读(2018版)》
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):486-490.
6
[Gastric stump carcinoma: frequency, treatment, complications and prognosis].[残胃癌:发病率、治疗、并发症及预后]
Chirurg. 2017 Apr;88(4):317-327. doi: 10.1007/s00104-016-0296-9.
7
Considerations on risk factors correlated to the occurrence of gastric stump cancer.关于与残胃癌发生相关的危险因素的思考
J Med Life. 2016 Apr-Jun;9(2):130-6.
8
Current status in remnant gastric cancer after distal gastrectomy.远端胃切除术后残胃癌的现状
World J Gastroenterol. 2016 Feb 28;22(8):2424-33. doi: 10.3748/wjg.v22.i8.2424.
9
Characteristics of gastric stump cancer: A single hospital retrospective analysis of 262 patients.胃残端癌的特征:对262例患者的单中心回顾性分析
Surgery. 2016 Jun;159(6):1539-1547. doi: 10.1016/j.surg.2016.01.003. Epub 2016 Feb 12.
10
Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association.残胃癌真的与原发性胃癌不同吗?日本胃癌协会特别工作组对文献的系统评价
Gastric Cancer. 2016 Apr;19(2):339-349. doi: 10.1007/s10120-015-0582-0. Epub 2015 Dec 14.

胃残端癌的吻合口部位癌与残端癌之间有差异吗?——对90例患者的单机构分析

Is there difference between anastomotic site and remnant stump carcinoma in gastric stump cancers?-a single institute analysis of 90 patients.

作者信息

Chowdappa Ramachandra, Tiwari Ajeet Ramamani, Ranganath Namrata, Kumar Rekha V

机构信息

Department of Surgical Oncology, Kidwai Cancer Institute, Bengaluru, India.

Department of Anaesthesia and Pain Relief, Kidwai Cancer Institute, Bengaluru, India.

出版信息

J Gastrointest Oncol. 2019 Apr;10(2):307-313. doi: 10.21037/jgo.2018.12.03.

DOI:10.21037/jgo.2018.12.03
PMID:31032099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6465485/
Abstract

BACKGROUND

Little has been reported regarding differences between malignancies that develop at the anastomotic site (ASC) and those that develop at the remnant stump (RSC) in gastric stump carcinomas (GSC). The purpose of our study was to compare clinical, pathological and survival characteristics of ASC patients with those of RSC patients.

METHODS

Patients who underwent surgery for GSC between January 2005 and December 2017 were analyzed. Of the total 112 patients, 22 patients were excluded from the study due to extensive loss of data. Ninety patients underwent curative resection and were evaluated based on anatomic site at which they developed malignancy, i.e., ASC and RSC. Clinical, pathological and survival characteristics were assessed.

RESULTS

As per Lauren's classification, diffuse and intestinal variety were significantly associated with ASC (P=0.0001) and RSC (P=0.0001) respectively. RSC was associated with lower pT [pT2, 15/33 (45.5%), P=0.0002]. ASC was significantly associated with higher pN [pN3, 30/57 (52.6%), P=0.0013], stage [stage III, 48/57 (84.2%), P=0.0022], positive mesenteric nodes (P=0.006) and poor 3-year survival (10.5% versus 36.4%, P=0.003).

CONCLUSIONS

ASC is substantially different than RSC. ASC is more aggressive disease compared to RSC and has different pathophysiology, higher rates of nodal involvement (both primary and mesenteric), presents with higher stage and has significantly poor 3-year survival.

摘要

背景

关于胃残端癌(GSC)吻合口部位发生的恶性肿瘤(ASC)与残端发生的恶性肿瘤(RSC)之间的差异,鲜有报道。我们研究的目的是比较ASC患者与RSC患者的临床、病理和生存特征。

方法

分析2005年1月至2017年12月期间接受GSC手术的患者。在总共112例患者中,22例患者因数据大量缺失被排除在研究之外。90例患者接受了根治性切除,并根据发生恶性肿瘤的解剖部位,即ASC和RSC进行评估。评估临床、病理和生存特征。

结果

根据劳伦分类法,弥漫型和肠型分别与ASC(P = 0.0001)和RSC(P = 0.0001)显著相关。RSC与较低的pT相关[pT2,15/33(45.5%),P = 0.0002]。ASC与较高的pN显著相关[pN3,30/57(52.6%),P = 0.0013]、分期[III期,48/57(84.2%), P = 0.0022]、阳性肠系膜淋巴结(P = 0.006)以及较差的3年生存率(10.5%对36.4%,P = 0.003)。

结论

ASC与RSC有很大不同。与RSC相比,ASC是侵袭性更强的疾病,具有不同的病理生理学,淋巴结受累率更高(包括原发和肠系膜淋巴结),分期更高,3年生存率显著较差。